tiprankstipranks
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market
KHTRF
Knight Therapeutics
RESEARCH TOOLSreports
Want to see KHTRF full AI Analyst Report?

Knight Therapeutics (KHTRF) Income Statement

32 Followers

Knight Therapeutics Income Statement

Last quarter (Q4 2025), Knight Therapeutics's total revenue was C$133.11M, an increase of 37.42% from the same quarter last year. In Q4, Knight Therapeutics's net income was C$8.85M. See Knight Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 450.09MC$ 371.30MC$ 328.20MC$ 293.56MC$ 243.48M
Gross Profit
C$ 150.74MC$ 174.41MC$ 152.65MC$ 138.06MC$ 115.41M
Operating Expenses
C$ 152.94MC$ 167.01MC$ 155.54MC$ 155.12MC$ 128.24M
Depreciation and Amortization
C$ 56.57MC$ 53.11MC$ 50.40MC$ 62.62MC$ 47.91M
EBITDA
C$ 54.37MC$ 64.38MC$ 40.90MC$ 25.26MC$ 42.59M
Operating Income
C$ -2.20MC$ 7.40MC$ -2.89MC$ -2.40MC$ -5.32M
Other Income/Expenses
C$ -4.50MC$ -5.34MC$ -19.10MC$ -2.92MC$ 19.52M
Pretax Income
C$ -6.70MC$ 2.05MC$ -21.99MC$ -43.96MC$ 6.69M
Net Income
C$ -5.37MC$ 4.33MC$ -16.84MC$ -29.89MC$ 15.68M
Per Share Metrics
Basic EPS
C$ -0.05C$ 0.04C$ -0.16C$ -0.26C$ 0.13
Diluted EPS
C$ -0.05C$ 0.04C$ -0.16C$ -0.26C$ 0.13
Weighted Average Shares Outstanding
 99.57M 101.04M 107.47M 114.89M 124.48M
Weighted Average Shares Outstanding (Diluted)
 99.57M 101.44M 107.47M 114.89M 124.52M
Currency in CAD

Knight Therapeutics Earnings and Revenue History